These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 29414279)

  • 1. Mogamulizumab (Anti-CCR4) in HTLV-1-Associated Myelopathy.
    Sato T; Coler-Reilly ALG; Yagishita N; Araya N; Inoue E; Furuta R; Watanabe T; Uchimaru K; Matsuoka M; Matsumoto N; Hasegawa Y; Yamano Y
    N Engl J Med; 2018 Feb; 378(6):529-538. PubMed ID: 29414279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mogamulizumab, an anti-CCR4 antibody, targets human T-lymphotropic virus type 1-infected CD8+ and CD4+ T cells to treat associated myelopathy.
    Yamauchi J; Coler-Reilly A; Sato T; Araya N; Yagishita N; Ando H; Kunitomo Y; Takahashi K; Tanaka Y; Shibagaki Y; Nishioka K; Nakajima T; Hasegawa Y; Utsunomiya A; Kimura K; Yamano Y
    J Infect Dis; 2015 Jan; 211(2):238-48. PubMed ID: 25104771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term safety and efficacy of mogamulizumab (anti-CCR4) for treating virus-associated myelopathy.
    Sato T; Yamauchi J; Yagishita N; Araya N; Takao N; Ohta Y; Inoue E; Takahashi M; Yamagishi M; Suzuki Y; Uchimaru K; Matsumoto N; Hasegawa Y; Yamano Y
    Brain; 2023 Aug; 146(8):3181-3191. PubMed ID: 37093965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mogamulizumab for Treatment of Human T-lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis: A Single-Center US-based Series.
    Meyerowitz EA; Mukerji SS; Kyle Harrold G; Erdil RM; Chen ST; Rudmann EA; Tsibris A; Venna N; Robbins GK
    Clin Infect Dis; 2023 Sep; 77(6):851-856. PubMed ID: 37157862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter, randomized, double-blind, placebo-controlled phase 3 study of mogamulizumab with open-label extension study in a minimum number of patients with human T-cell leukemia virus type-1-associated myelopathy.
    Sato T; Nagai M; Watanabe O; Misu T; Takenouchi N; Ohkubo R; Ishihara S; Tsuboi Y; Katsuno M; Nakagawa M; Matsushita T; Aso Y; Matsuura E; Tokashiki T; Mukaino A; Adachi H; Nakanishi K; Yamaguchi Y; Yamaguchi S; Yamano Y
    J Neurol; 2024 Jun; 271(6):3471-3485. PubMed ID: 38430272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adult T-cell leukemia-lymphoma complicated by Takotsubo cardiomyopathy and HTLV-1-associated myelopathy after treatment with the anti-CCR4 antibody mogamulizumab].
    Yamanaka S; Nakayama K; Tamai H; Sakamaki M; Inokuchi K
    Rinsho Ketsueki; 2017; 58(4):309-314. PubMed ID: 28484158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
    Gessain A; Mahieux R
    Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human T lymphotropic virus type I (HTLV-I) proviral load in cerebrospinal fluid: a new criterion for the diagnosis of HTLV-I-associated myelopathy/tropical spastic paraparesis?
    Lezin A; Olindo S; Oliere S; Varrin-Doyer M; Marlin R; Cabre P; Smadja D; Cesaire R
    J Infect Dis; 2005 Jun; 191(11):1830-4. PubMed ID: 15871115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HTLV-1 induces a Th1-like state in CD4+CCR4+ T cells.
    Araya N; Sato T; Ando H; Tomaru U; Yoshida M; Coler-Reilly A; Yagishita N; Yamauchi J; Hasegawa A; Kannagi M; Hasegawa Y; Takahashi K; Kunitomo Y; Tanaka Y; Nakajima T; Nishioka K; Utsunomiya A; Jacobson S; Yamano Y
    J Clin Invest; 2014 Aug; 124(8):3431-42. PubMed ID: 24960164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Burbelo PD; Meoli E; Leahy HP; Graham J; Yao K; Oh U; Janik JE; Mahieux R; Kashanchi F; Iadarola MJ; Jacobson S
    Retrovirology; 2008 Oct; 5():96. PubMed ID: 18937847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Developing novel treatments for HTLV-1-associated myelopathy (HAM) by investigating molecular pathomechanisms].
    Araya N; Sato T; Coler-Reilly A; Yagishita N; Yamano Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(3):207-12. PubMed ID: 27320936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disulfide-mediated apoptosis of human T-lymphotrophc virus type-I (HTLV-I)-infected cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Nishiura Y; Nakamura T; Fukushima N; Nakamura H; Ida H; Aramaki T; Eguchi K
    Antivir Ther; 2009; 14(4):533-42. PubMed ID: 19578238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1-infected patients.
    Casseb J; de Oliveira AC; Vergara MP; Montanheiro P; Bonasser F; Meilman Ferreira C; Smid J; Duarte AJ
    J Med Virol; 2008 Mar; 80(3):392-8. PubMed ID: 18205234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP.
    Grassi MF; Olavarria VN; Kruschewsky Rde A; Mascarenhas RE; Dourado I; Correia LC; de Castro-Costa CM; Galvão-Castro B
    J Med Virol; 2011 Jul; 83(7):1269-74. PubMed ID: 21567429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of HAM/TSP from patients with multiple sclerosis infected with HTLV-I.
    Puccioni-Sohler M; Yamano Y; Rios M; Carvalho SM; Vasconcelos CC; Papais-Alvarenga R; Jacobson S
    Neurology; 2007 Jan; 68(3):206-13. PubMed ID: 17224575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring the HTLV-1 proviral load in the peripheral blood of asymptomatic carriers and patients with HTLV-associated myelopathy/tropical spastic paraparesis from a Brazilian cohort: ROC curve analysis to establish the threshold for risk disease.
    Furtado Mdos S; Andrade RG; Romanelli LC; Ribeiro MA; Ribas JG; Torres EB; Barbosa-Stancioli EF; Proietti AB; Martins ML
    J Med Virol; 2012 Apr; 84(4):664-71. PubMed ID: 22337307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HTLV-1 proviral load in peripheral blood mononuclear cells quantified in 100 HAM/TSP patients: a marker of disease progression.
    Olindo S; Lézin A; Cabre P; Merle H; Saint-Vil M; Edimonana Kaptue M; Signate A; Césaire R; Smadja D
    J Neurol Sci; 2005 Oct; 237(1-2):53-9. PubMed ID: 15972218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of T Regulatory Lymphocytes Transcription Factors in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) Patients.
    Ghezeldasht SA; Sadeghian H; Azarpazhooh MR; Shamsian SAA; Rafatpanah H; Mahmoodi M; Rezaee SA
    Appl Biochem Biotechnol; 2017 Aug; 182(4):1403-1414. PubMed ID: 28101786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-alpha therapy for HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Saito M; Nakagawa M; Kaseda S; Matsuzaki T; Jonosono M; Eiraku N; Kubota R; Takenouchi N; Nagai M; Furukawa Y; Usuku K; Izumo S; Osame M
    J Infect Dis; 2004 Jan; 189(1):29-40. PubMed ID: 14702150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High IFN-γ/IL-10 expression ratio and increased frequency of persistent human T-cell lymphotropic virus type 1-infected clones are associated with human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis development.
    Espíndola OM; Oliveira LC; Ferreira PM; Leite AC; Lima MA; Andrada-Serpa MJ
    Intervirology; 2015; 58(2):106-14. PubMed ID: 25833232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.